As monkeypox cases surge in South Africa, the World Health Organization (WHO) has raised its response level to the highest tier. In the face of this global public health challenge, Tianlong is committed to contributing Chinese expertise and solutions to the fight against the outbreak.
Tianlong’s Monkeypox Virus Nucleic Acid Detection Kit, based on fluorescent PCR technology, offers an advanced one-tube method with a sensitivity of 200 copies/mL. This rapid detection system can deliver results within 40min, providing a robust tool for early screening and precise control of the monkeypox virus.
In 2022, our Monkeypox Detection Kit participated in the global Poxviruses EQA pilot study organized by QCMD and successfully achieved a 100% pass rate. Additionally, the kit has also obtained CE certification from the EU and MHRA registration from the UK.
Tianlong has been contributing to the prevention and control of monkeypox infections in over 10 countries, including Spain, Saudi Arabia, South Korea, Jordan, Indonesia, and Greece. Stay tuned for more updates as we continue to empower global public health with our innovative solutions.
